Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
AstraZeneca
Federal Trade Commission
Teva
Colorcon
Harvard Business School
Healthtrust
Cipla
Merck

Generated: September 25, 2018

DrugPatentWatch Database Preview

DEXRAZOXANE HYDROCHLORIDE - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for dexrazoxane hydrochloride and what is the scope of dexrazoxane hydrochloride patent protection?

Dexrazoxane hydrochloride is the generic ingredient in three branded drugs marketed by Gland Pharma Ltd, Mylan Institutional, West-ward Pharms Int, Clinigen Hlthcare, and Pharmacia And Upjohn, and is included in five NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for dexrazoxane hydrochloride. Seven suppliers are listed for this compound.

Pharmacology for DEXRAZOXANE HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for DEXRAZOXANE HYDROCHLORIDE
Synonyms for DEXRAZOXANE HYDROCHLORIDE
(+)-Razoxane hydrochloride
(S)-4,4'-(1-Methyl-1,2-ethanediyl)bis-2,6-piperazinedione hydrochloride
(S)-4,4'-(propane-1,2-diyl)bis(piperazine-2,6-dione) hydrochloride
003D010
1263283-43-7
149003-01-0
2,6-Piperazinedione, 4,4'-((1S)-1-methyl-1,2-ethanediyl)bis-, hydrochloride (1:1)
2,6-Piperazinedione, 4,4'-(1-methyl-1,2-ethanediyl)bis-, hydrochloride, (S)-
4-[(2S)-2-(3,5-dioxopiperazin-1-yl)propyl]piperazine-2,6-dione hydrochloride
5346058Q7S
AC-9014
AC1OCF6D
ADR-529
ADR-529 hydrochloride
AKOS015900046
AN-7454
AOB6763
AOB6863
API0005176
AS-16976
C11H16N4O4.HCl
Cardioxane
CHEBI:50224
CHEMBL1200778
CS-0767
D07807
Dexrazoxane (Hydrochloride)
Dexrazoxane (TN)
Dexrazoxane HCl
Dexrazoxane hydrochloride [ORANGE BOOK]
Dexrazoxane hydrochloride [VANDF]
Dexrazoxane hydrochloride [WHO-DD]
DTXSID60164152
FT-0700082
HY-76201
I14-10061
ICRF 187 hydrochloride
ICRF-187 hydrochloride
KDX-0811
MolPort-023-276-958
Razoxane (+)-form hydrochloride [MI]
Razoxane hydrochloride, (S)-
s1222
Savene
Savene (TN)
SCHEMBL18188
TopoTect
Totect
Totect (TN)
UNII-5346058Q7S
UNII-BR9T89F617 component BIFMNMPSIYHKDN-FJXQXJEOSA-N
W-5214
X5010
Zinecard
Zinecard (TN)

US Patents and Regulatory Information for DEXRAZOXANE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
West-ward Pharms Int DEXRAZOXANE HYDROCHLORIDE dexrazoxane hydrochloride INJECTABLE;INJECTION 076068-001 Sep 28, 2004 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pharmacia And Upjohn ZINECARD dexrazoxane hydrochloride INJECTABLE;INJECTION 020212-001 May 26, 1995 AP RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan Institutional DEXRAZOXANE HYDROCHLORIDE dexrazoxane hydrochloride INJECTABLE;INJECTION 200752-001 Oct 19, 2011 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Clinigen Hlthcare TOTECT dexrazoxane hydrochloride INJECTABLE;INJECTION 022025-001 Sep 6, 2007 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
West-ward Pharms Int DEXRAZOXANE HYDROCHLORIDE dexrazoxane hydrochloride INJECTABLE;INJECTION 076068-002 Sep 28, 2004 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Gland Pharma Ltd DEXRAZOXANE HYDROCHLORIDE dexrazoxane hydrochloride INJECTABLE;INJECTION 207321-001 Nov 28, 2016 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for DEXRAZOXANE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And Upjohn ZINECARD dexrazoxane hydrochloride INJECTABLE;INJECTION 020212-001 May 26, 1995 ➤ Sign Up ➤ Sign Up
Pharmacia And Upjohn ZINECARD dexrazoxane hydrochloride INJECTABLE;INJECTION 020212-002 May 26, 1995 ➤ Sign Up ➤ Sign Up
Pharmacia And Upjohn ZINECARD dexrazoxane hydrochloride INJECTABLE;INJECTION 020212-001 May 26, 1995 ➤ Sign Up ➤ Sign Up
Pharmacia And Upjohn ZINECARD dexrazoxane hydrochloride INJECTABLE;INJECTION 020212-002 May 26, 1995 ➤ Sign Up ➤ Sign Up
Pharmacia And Upjohn ZINECARD dexrazoxane hydrochloride INJECTABLE;INJECTION 020212-001 May 26, 1995 ➤ Sign Up ➤ Sign Up
Pharmacia And Upjohn ZINECARD dexrazoxane hydrochloride INJECTABLE;INJECTION 020212-002 May 26, 1995 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
AstraZeneca
Federal Trade Commission
Teva
Colorcon
Harvard Business School
Healthtrust
Cipla
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.